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Introduction
Extensive use of screening programs for breast cancer
has led to an increase in the number of detected nonpal-
pable lesions found in mammography. Microscopic veri-
fication of every detected lesion by means of a surgical
biopsy is not necessary and, what is more, impossible
Original contributions
Large core needle biopsy of nonpalpable breast lesions
Ewa Weso∏owska1, Ewa Dziewulska1, Justyna Okniƒska1,
Monika Nagadowska2, Danuta Pietrow3
I n t r o d u c t i o n.  An increasing number of nonpalpable abnormalities requiring breast biopsy are being identified due to the
widespread use of screening mammography. The advantage of large-core needle biopsy (LCNB) is that it allows histologic exa-
mination. The aim of the study was to present our own experience with LCNB and to determine the value of LCNB in the dia-
gnosis of nonpalpable breast lesions.
M a t e r i a l  a n d  m e t h o d s.  A total of 443 LCNB were done during the study period from December 1994 to June 1999.
Biopsy were performed with 14-gauge needle with stereotactic or ultrasound guidance. Microcalcifications constitued 90% of
all lesions. From each lesion 1-11 (mean 5) cores were taken. Radiography of core specimens was performed in cases in which
the target lesion contained microcalcifications.
Re s u l t s.  84 malignancies were identified. Surgical intervention was performed in 146 cases. Concordance between histo-
logic findings in the core and surgical sample was 86%. Specimen radiography of breast microcalcifications should be
routinely performed to ensure appropriate histological tissue. LCNB achieved good diagnostic yield with 5 specimens or
more. One cancer was found among 295 women with benign lesions in LCNB in whom follow-up examinations were per-
formed.
C o n c l u s i o n.  With sufficient experience, LCNB may prove to be an acceptable alternative to surgical biopsy in women with
breast lesions suspected at mammography.
Biopsja gruboig∏owa w niewyczuwalnych zmianach piersi
W s t ´ p.  Rozpowszechnienie badaƒ skryningowych spowodowa∏o wzrost liczby zmian subklinicznych piersi, wymagajàcych
weryfikacji mikroskopowej. Biopsja gruboig∏owa (BG) jest od niedawna stosowanà procedurà diagnostycznà, pozwalajàcà na
uzyskanie rozpoznania histopatologicznego. Celem pracy by∏a ocena wartoÊci BG.
M a t e r i a ∏  i m e t o d a.  W okresie od grudnia 1994 do czerwca 1999 r. wykonano 443 BG w niewyczuwalnych zmianach sut-
ka. Mikrozwapnienia stanowi∏y 90% zmian. Biopsje wykonywano pod kontrolà mammografii (401 przypadków) lub USG (42
przypadki), ig∏à o Êrednicy 2,1 mm, z u˝yciem automatycznego dzia∏a. Ka˝dorazowo pobierano Êrednio 5 preparatów tkanko-
wych do badania histopatologicznego.
W y n i k i.  Zmian´ z∏oÊliwà rozpoznano w 84 przypadkach (19%). Operowano 146 chorych. ZgodnoÊç rozpoznaƒ dla przy-
padków operowanych wynosi∏a 86%. Wykazano zale˝noÊç mi´dzy liczbà pobranych preparatów i obecnoÊcià w nich mikro-
zwapnieƒ, a wynikami histopatologicznymi. WÊród 295 kobiet z rozpoznaniem zmiany ∏agodnej w BG, u których wykonano
badania kontrolne, w trakcie obserwacji stwierdzono jeden przypadek raka.
W n i o s k i.  Biopsja gruboig∏owa mo˝e stanowiç alternatyw´ dla biopsji chirurgicznej pod warunkiem dobrego opanowania
techniki badania.
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from the practical standpoint. Large-core needle biopsy
(LCNB) is an alternative to diagnostic surgical procedu-
res. According to literature reports, this method has been
widely appraised in the diagnosis of breast lesions as less
invasive, more rapid and economically advisable [1-6].
The aim of this paper is to present our own experien-
ces acquired during several years of LCNB use and analy-
sis of its usefulness in clinically symptomless breast le-
sions with particular reference to mammographically de-
tected microcalcifications.
Material and methods
Between December 1992 and June 1999, LCNB was performed
in 443 cases of nonpalpable lesions revealed by mammography.
Biopsy was performed in 360 cases where microcalcifications
were the predominating finding and in 83 cases of the presence
of nodular changes. For each lesion the probability of malignan-
cy was predicted determining its category according to the BI-
-RADS classification (Breast Imaging Reporting and Data Sys-
tem) acc. to which category 3 stands for a probably benign lesion,
category 4 – a probably malignant lesion and category 5 a mali-
gnant lesion (Fig.1).
All biopsies were performed with a 2.1 mm diameter (14G)
needle using an automatic gun (Biopty, Bard) with a shooting
range 23 mm. In 401 cases biopsy was done under mammogra-
phic guidance using a device for invasive stereotactic procedures
connected with digital image processing (Lorad DSM). In 42
cases of nodular lesions the procedure was performed under
ultrasound (US) control (HDI 3000 ATL). All stereotactic pro-
cedures were carried out by radiologists specialized in invasive
diagnostic procedures. In 16 cases the biopsies were carried out
under US guidance by a surgeon cooperating with a radiolo-
gist. The choice of guidance modality was determined by the
radiologist.
Every procedure provided from 1 to 11 core biopsy speci-
mens for histological examination (mean: 5). If microcalcifica-
tions were discerned the specimens were subjected to radiogra-
phy in order to confirm their presence within the tissue sam-
ple. Indications for surgical intervation were as follows:
– diagnosis of malignancy
– diagnosis of atypical lesions
– high probability of malignancy in mammographic examina-
tion independently of LCNB results
– absence of microcalcifications in the obtained cores both on
X-ray films and in histological examination.
Fig. 1b. BIRADS „4” – Granular microcalcifications. Pathology: atypi-
cal ductal hyperplasia
Fig. 1c. BIRADS „5” – Cluster of fine linear branching microcalcifica-
tions. Pathology: ductal carcinoma in situ
Fig. 1 a. BIRADS „3” – Round, regular microcalcifications. Pathology:
fibrocystic changes
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Results
Histological examination of 443 samples revealed 84 cases
of malignant lesions, with ductal carcinoma in situ (DCIS)
in 46 cases. In 359 cases benign lesions were found,
among them fibrocystic changes in 308 cases, atypical
ductal hyperplasia (ADH) in 28 cases, fibroadenoma in 7
cases and normal glandular tissue in 16 cases.
In 295 cases of benign lesions diagnosed by LCNB
there followed a suggestion of observation and clinical
examination with mammography. In 285 cases it took
place after 6 months with stationary mammographic fin-
dings in 281 patients. In the four remaining cases an incre-
ase of microcalcifications was found and another micro-
scopic verification was suggested; in three cases diagnostic
surgical biopsy revealed benign lesions, while in one case
carcinoma was found (Fig. 2).
148 patients were qualified for operation, two of
them refused surgical treatment despite malignancies in
LCNB; 146 patients underwent operation.
In case of 38 patients with invasive carcinoma surgi-
cal intervention provided material which confirmed the
presence of malignancy in histological examination.
The diagnosis of DCIS was confirmed in 32 cases
(71%) while in 12 cases (27%) invasive carcinoma coexi-
sted with intraductal component. In one patient no cancer
was found in the surgical specimen.
Further analysis of the 28 cases of ADH revealed
the following figures: 11 cases (39%) of confirmed dia-
gnosis, 3 cases (11%) of benign lesions without atypia,
14 cases (50%) of malignancy, including 7 cases of DCIS
(Fig. 3).
Despite a diagnosis of benign lesions in LCNB 20
patients qualified for surgical biopsy because the changes
found in mammographic picture were highly suggestive of
malignancy. Among them 11 carcinomas were found in
Fig. 2 a. Cluster of fine, irregular microcalcifications.
Pathology: LCNB – fibrocystic changes
Fig. 2 b. After 6 months increasing in number of microcalcifications
(b' – magnified view). Pathology: Excisional biopsy – invasive lobular
carcinoma 5 mm in size
Fig. 2 b'.
Fig. 3. Close to coarse, popcorn-like calcification cluster of fine, punc-
tate microcalcifications.
Pathology: LCNB – Atypical ductal hyperplasia.
Excisional biopsy – Ductal carcinoma in situ closed, but not related to
involuting fibroadenoma.
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postoperative histological examination, including 7 cases
of DCIS.
In 23 cases microcalcifications were not revealed in
specimen radiographies and histological examinations.
Surgical biopsy was performed in 21 of these patients re-
vealing 8 cases (38%) of carcinoma. It shows that the ac-
curacy of diagnosis by histological examination depends
on the presence of microcalcifications in the core biopsy
specimens (Table I).
In the group of 146 surgically treated patients there
were 42 cases in which LCNB provided from 1 to 4 core
biopsy specimens. In this group the diagnoses were cor-
rect in 57% of cases. However when 5 to 11 specimens
were taken the histological diagnosis was correct  in 95
out of 104 cases (91%) (Table II).
The results of histological examinations after LCNB
and after surgical biopsy are compared in Table III. Com-
plete concordance between core biopsy findings and sur-
gical findings was found in 107 cases (73%) including
a case of carcinoma correctly diagnosed after LCNB but
not found in the surgical specimen. Partial concordance
ocurred in 19 cases (13%). This group includes ADH ca-
ses with a final diagnosis of DCIS and cases of DCIS fo-
und to be invasive in surgical biopsy material.
A lack of concordance in diagnosis occurred in 20 ca-
ses (14%) initially pronounced as benign lesions, and fo-
und to be malignant in postoperative verification.
Table IV presents the diagnostic value of LCNB.
The sensitivity of the method is 75%, specificity – 100%.
In the entire material consisting of 443 patients undergo-
ing LCNB there were only two cases (0.5%) of complica-
tions: in one case moderately profuse bleeding rendered
completion of the procedure impossible, however surgical
intervention was not necessary; in another case infection
developed, successfully treated with antibiotics.
Discussion
Nonpalpable lesions detected in mammography demand
microscopic verification, which is indispensable for esta-
blishing diagnosis and applying adequate treatment. The
accepted standard management is surgical removal of
the lesion under image guidance followed by histological
examination. This is an invasive procedure associated
with certain risks, costly and not necessarily effective [7].
In many clinical centers stereotactic fine-needle biopsy
has been introduced in diagnostic management as a more
simple and effective method [8-10] however it has signifi-
cant drawbacks. Insufficient sampling rates range from
6% to 47%, false negative results occur in 1% to 31% of
cases, false positive results occur also, but sporadically
(below 1%). It is not possible to differentiate between in
situ and invasive carcinomas. Cytological examination
must be performed by a specially trained pathologist. For
Tab. I. Biopsy results related to the presence of microcalcifications in
radiography of core specimens (in 121 cases of microcalcifications)
Microcalcifications LCNB versus excisional biopsy
in core specimens
Concordant Discordant
yes 90 10
no 13 8
p<0.001
Tab. II. Biopsy results related to the number of core biopsies.
No. of cores LCNB versus excisional biopsy
Concordant Discordant
1-4 24 18
5-11 95 9
p<0.001
Tab. III. Comparison of histopathologic results of LCNB and excisional biopsy
LCNB Excisional biopsy
Benign Atypical ductal Ductal carcinoma Invasive Total
lesions hyperplasia in situ carcinoma
Benign lesions 19 4 7 6 36
Atypical ductal hyperplasia 3 11 7 7 28
Ductal carcinoma in situ 1 32 12 45
Invasive carcinoma 37 37
Total 23 15 46 62 146
Tab. IV. Diagnostic value of LCNB
Ex.biopsy Ex. biopsy
+ -
LCNB + 82 0 82
LCNB - 27 37 64
Total 109 37 146
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these reasons, LCNB seems most appropriate for obta-
ining tissue fragments for histological examination. The
pathologist can establish a final diagnosis with a more
complete characterization of malignant lesions or may
recognize the type of benign lesions. Diagnostic effective-
ness of LCNB equals that of surgical biopsy being, at the
same time, less invasive and bringing on no changes in
mammographic pattern or skin scar [1-3, 11]. If a lesion
observed in mammography may be discerned under US
the biopsy should be performed under ultrasound gu-
idance. Such a procedure is less time-consuming, less co-
stly and allows for a more correct estimation of the actu-
al position of needle tip in relation to the lesion. A peru-
sal of the pertinent literature shows that that the
percentage of US-guided biopsies ranges from 0% to
60% in various centers [3]. In our laboratory about 10%
of biopsies were US-guided, performed exclusively in ca-
ses of nodular lesions.
An important factor affecting the quality of the re-
sults is the experience of the radiologist performing this
procedure. In our material a majority of the false negati-
ve results ocurred in the initial period of LCNB intro-
duction as a diagnostic method.
The presented results assessing LCNB value are so-
mewhat poorer than those reported in literature, in which
the unison of LCNB diagnoses with the results of surgical
biopsy frequently exceeded 90% and the ratio of false
negative results was below 10% [1-3]. This is evidence of
LCNB limitations as a diagnostic method which are due,
most frequently, to inadequate calibration of the unit,
faulty localization of the lesion or qualifying lesions below
5 mm for the procedure i.e. too small in size.
Significant diagnostic problems are encountered in
cases of ADH diagnosed by LCNB, since their differentia-
tion against DCIS is difficult. Therefore all cases of ADH
should be verified by surgical biopsy. According to litera-
ture data the amount of carcinoma found in surgical spe-
cimens reaches 50% [12, 13].
The concordance between the results of histologi-
cal examinations of LCNB material and postoperative
results depends also on the number of core biopsy speci-
mens obtained during the procedure and the presence
of microcalcifications in the samples. In our material the
percentage of false negative results was high (38%) when
no microcalcifications were found either in specimen
radiographies and on histological examination. This
was probably caused by erroneous localization of the
biopsy site.
There exist no absolute contraindications to LCNB.
When the procedure is performed under mammography
guidance the limitations result from technical difficulties
eg. lesions situated at the periphery (that is near the chest
wall or skin), or in cases of small breasts with thickness
after compression insufficient for biopsy gun shot (breast
thickness below 3 cm).
LCNB is well tolerated by the patients and only rare-
ly causes major complications, such as bleeding requiring
surgical intervention, purulent mastitis requiring draina-
ge and antibiotic treatment or pneumothorax [3, 6].
In the population of women with lesions detected
by screening mammography the majority of findings are
probably benign (BIRADS 3). In these cases negative
LCNB results confirms the benign character of the le-
sions. After a time interval previously unrecognised mali-
gnant lesions may occur which had not been recognized
before despite correctly performed LCNB. These cases
are rare and owing to slow progression the prognosis is
usually good despite a delay in diagnosis and treatment.
LCNB was shown to produce no changes in the breast,
contrary to surgical biopsy [11] and thus control mam-
mographic examinations are more effective after LCNB
than after surgical biopsy.
In recent years vacuum assisted biopsy (VAB) has
been introduced for invasive procedures. This method is
an automated biopsy gun-needle combinet with a directio-
nal, stereotactic, vacuum-assisted biopsy system. The pro-
cedure has all the advantages of LCNB and ensures bet-
ter quality of the obtained samples. An important advan-
tage is the possibility of obtaining many, samples without
removing the needle and cutting samples of a greater vo-
lume. According to literature data the percentage of fal-
se negative results does not exceed 5% [16-18].
Conclusions
On the basis of the presented material it may be stated
that LCNB renders histological diagnosis of nonpalpa-
ble breast lesions without the necessity of performing co-
stly and risky open biopsy possible in most cases. At least
five core specimens should be taken for histological exa-
mination and, in case of microcalcifications, their pre-
sence should be ascertained. The results of mammogra-
phy must be considered when planning further manage-
ment. Obtaining high value diagnostic results requires
mastering the procedure technique and acquiring exten-
sive experience as well as close cooperation of radiologi-
sts, surgeons and pathologists.
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